Bumble (BMBL) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

BMBL Bumble

Watchlist

8.590
-0.260-2.94%

Close Nov 12 16:00 ET

8.660
+0.070+0.81%

Post 20:01 ET

929.29MMarket Cap-1819P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

There's Reason For Concern Over Bumble Inc.'s (NASDAQ:BMBL) Massive 30% Price Jump
Simply Wall StNov 12 06:50 ET
Where Bumble Stands With Analysts
BenzingaNov 11 16:00 ET
Bumble Catalysts Show Efficiency Gains, But Analyst Flags Growth Risks
BenzingaNov 11 13:31 ET
Bumble Shares Are Trading Higher. Susquehanna Raised Its Price Target on the Stock From $6 to $8.
BenzingaNov 11 13:28 ET
Bumble Surpasses Q3 Estimates but Analysts Warn of User Growth Challenges Ahead | NASDAQ:BMBL
Proactive InvestorsNov 11 13:13 ET
Analysts Can't Decide to Swipe Left or Right on Dating Apps -- Market Talk
WSJNov 11 11:41 ET

Comments

Movers and Shakers

Sep 27 07:36

Columns Today's Pre-Market Movers and Top Ratings | COST, DG, BMBL, HPQ and More

Morning Movers
Gapping up
$Bristol-Myers Squibb (BMY.US)$ Shares jumped 3.8% after the FDA approved Cobenfy as a new treatment for schizophrenia in adults, marking the first novel treatment for the mental disorder in several decades.
$Wynn Resorts (WYNN.US)$ Shares climbed 1.7% following an upgrade to overweight from equal weight by Morgan Stanley, which highlighted the company's strong fundamentals compared to its competitors...

Expand

jimmy the trader

Aug 26 09:44

Any reason why you’d think this company would recover?

$Bumble (BMBL.US)$

Stock_Drift

Aug 18 06:01

💸💸💸💸💸
$Bumble (BMBL.US)$

Kevin Travers

Aug 8 10:24

Columns Earnings Bite Consumer Stocks, Besides Weightloss | Moovin Stonks

Good morning, traders. Happy Thursday, the market is trying to climb up after falling back. The Nasdaq and tech stocks were still in correction territory from their heights in the lush days of July. My name is Kevin Travers, here are moovin' stonks.
Eli Lilly $Eli Lilly and Co (LLY.US)$ posted a Q2 earnings beat, boosted by demand for the company's Mounjaro diabetes treatment and weight-loss drug Zepbound. The stock climbed 8%, and ...